Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Harpoon Therapeutics, Inc.
| Metric | Harpoon Therapeutics, Inc. Healthcare |
|---|---|
| Quality Score | 37 / 100 |
| Revenue (latest) | $32M |
| Net income (latest) | −$68M |
| Operating margin | −214.1% |
| Net margin | −212.2% |
| Return on equity | −1254.5% |
| Return on assets | −91.9% |
| Return on capital (ROCE) | −320.8% |
| Debt / equity | 12.66× |
| Revenue growth (YoY) | 34.9% |
| Altman Z″ (distress) | -21.53 |
| Accruals / assets | 29.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.